drugset / Trial / NCT03276325
Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery
RandomizedParallel-groupDouble-blindOther
Summary
Intraoperative pain, nausea, vomiting, hypotension, bradycardia are known side effects during lower abdominal surgery under spinal anesthesia, Time to 2 segment regression of sensory block and duration of effective analgesia prolonged with intrathecal (IT) 0.4 mg nalbuphine \& IT 0.8 mg nalbuphine, but the incidence of side-effects was significantly higher with IT 0.8 mg nalbuphine compared with (IT) 0.4 mg nalbuphine.
Timeline
- Start
- 2017-09-15
- Primary completion
- 2018-01-01
- Completion
- 2018-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 8 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 4 ml | Other |
| Comparator | Nalbuphine | Small molecule | 0.6 mg | Other |
Indications
No indication recorded.